Genotype is becoming increasingly important for the management of cardiomyopathy patients. Stay tuned with these fast evolving concepts. Join the next HeartMuscleTalks session!

It makes me so incredibly sad. Prof Rapezzi was a wonderful generous man and expert. We owe him so much in the field of amyloidosis and cardiomyopathies. I still remember when we first met and how he selflessly accepted to come to Romania to spread his knowledge! RIP

Excellent concept!

Team work and team prizes. JTeam at Societatea Romana de Cardiologie 2022. Ruxandra Jurcut Adrian Giucă, M.D.

So happy to be part of this project! ERN GUARD-Heart Connie Bezzina Prof. Arthur Wilde Lia Crotti

What a joy, to see the work of this big international expert group published in JASE! Thank you for your commitment and having us on board of this exciting project!
sciencedirect.com/science/articl…
Nina Ajmone Marsan Victoria Delgado Bogdan A. Popescu Robert Adam

🔥 Just published at EHJ-CVI!

#EACVI survey on multimodality imaging assessment or the right heart

A superb collaborative team work of the EACVI Scientific Initiatives Committee Shruti Joshi Marc Dweck

Open access via this link

👇🏼👇🏼

🔗 academic.oup.com/ehjcimaging/ad…

Oh yessss!! So important indeed!
Thanks Donal 🙏🙏

EACVI dream team 💪💪 EACVIPresident Steffen Petersen Blazej Michalski Hatem Soliman, MSc, FEACVI, FASE, FHEA Augustin Coisne Victoria Delgado Denisa Muraru Ruxandra Jurcut Thor Edvardsen Charles Fauvel Yohann bohbot SFCARDIO cardio-online 🫀 CCF

💥My top 10 learning points from the #ESCCongress 2022💥

A thread for cardiologists/general physicians

1) Addition of IV acetazolamide to IV furosemide in AHF results in 46% higher incidence of successful decongestion after 3 days

EVIDENCE: ADVOR nejm.org/doi/full/10.10…

True extravaganza & cardiac imaging = ❤️
With fantastic Stephan Achenbach

Women transforming leadership programme friends back together! Ruxandra Jurcut

#ESCCongress : New PH guidelines and new echo parameter! TAPSE/sPAP is there!

Threshold: 0.55 for screening, 0.32 for risk stratification!

SFCARDIO HTaPFrance European Society of Cardiology Guillaume Bonnet Théo Pezel Olivier Raitière ERS

This is how to follow the new ESC guidelines. Fantastic talks given by PH panelists. Worried about how much larger our PH cohort might become with the new cutoffs but happy to have good guidance!
#esccongress2022 #ESCGuidelines European Society of Cardiology Jean-Luc Vachiery 🫀 Adrian Giucă, M.D.

#DELIVER trial: dapagliflozin reduces the risk of #cardiovascular death or worsening #heartfailure in HF patients with mildly reduced and preserved ejection fraction.

#ESCCongress